Doktorsitesi.com

Primitive Neuroectodermal Tumor of the Testis.

Doç. Dr. Cevper Ersöz
Doç. Dr. Cevper Ersöz
5 Haziran 2024163 görüntülenme
Randevu Al
A 21-year male presenting with left testicular mass and retroperitoneal lymphadenopathy underwent radical orchiectomy; and his pathological examination showed a mixed germ cell tumor composed of primitive neuroectodermal tumor mixed with mature teratoma. Six cycles of IE (ifosfamide, etoposide) and VAC (vincristine, doxorubicin, cyclophosphamide) chemotherapy were given after sperm preservation. He then underwent retroperitoneal lymph node dissection (RPLND). No tumor was detected in the removed lymph nodes, and all lymph nodes were reported as showing reactive changes. Key Words: Chemotherapy, Primitive neuroectodermal tumor, Surgery, Teratom, Testis.
Primitive Neuroectodermal Tumor of the Testis.
Yapay Zeka ile geliştirilmiş versiyon

İçerik yapay zeka ile optimize edilmiştir

Introduction to Testicular Mixed Germ Cell Tumor Case

This case study examines the clinical progression and treatment of a 21-year-old male patient presenting with a left testicular mass and retroperitoneal lymphadenopathy. The management of such complex cases requires a precise diagnostic approach and a multimodal treatment strategy to address the aggressive nature of the malignancy.

Diagnosis and Pathological Examination

Following the initial presentation, the patient underwent a radical orchiectomy to remove the primary tumor. The subsequent pathological examination revealed a mixed germ cell tumor, which was uniquely composed of two distinct components:

  • Primitive Neuroectodermal Tumor (PNET): A rare and aggressive neuroepithelial tumor.
  • Mature Teratoma: A more common component of germ cell malignancies.

Multimodal Treatment and Chemotherapy Protocol

Prior to initiating systemic therapy, sperm preservation was performed to protect the patient's future reproductive health. The oncology team then administered a comprehensive chemotherapy regimen consisting of six cycles of alternating protocols. The treatment included the following agents:

ProtocolChemotherapeutic Agents
IE RegimenIfosfamide and Etoposide
VAC RegimenVincristine, Doxorubicin, and Cyclophosphamide

Surgical Intervention and Post-Treatment Outcomes

After completing the chemotherapy cycles, the patient underwent retroperitoneal lymph node dissection (RPLND) to address the initial lymphadenopathy. This surgical intervention is critical for assessing the efficacy of the systemic treatment and ensuring the removal of any residual disease.

Pathological Results of RPLND

The final pathological report of the removed lymph nodes indicated a highly favorable outcome. No tumor cells were detected in the specimens. All examined lymph nodes were reported as showing only reactive changes, confirming a complete pathological response to the administered treatment plan.

Conclusion

The successful management of this mixed germ cell tumor involving PNET and mature teratoma highlights the importance of combining radical surgery with intensive chemotherapy. This case underscores the effectiveness of the IE/VAC regimen followed by RPLND in achieving a tumor-free status in young adult patients.

Etiketler

Testis tümörleri

Yazar Hakkında

Doç. Dr. Cevper Ersöz

Doç. Dr. Cevper Ersöz

Doç. Dr. Cevper ERSÖZ, 2012 den itibaren Üroloji Uzmanı olarak çalışmaktadır. 12 yıllık cerrahi ve hasta muayene deneyimine sahip olmakla birlikte, yaklaşık 10.000 den fazla orta ve büyük ölçekli ürolojik cerrahi ameliyatını gerçekleştirmiştir. Özellikle ilgi alanı olan Böbrek Tümörü, Prostat Kanseri, Mesane Kanseri ve Testis kanseri gibi ürolojik kanserlerin tedavi deneyimine sahiptir.

Önemli Bilgilendirme

Site içerisinde bulunan bilgiler bilgilendirme amaçlıdır. Bu bilgilendirme kesinlikle hekimin hastasını tıbbi amaçla muayene etmesi veya tanı koyması yerine geçmez.